Frequency of pathogenic germline variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in ductal carcinoma in situ diagnosed in women under the age of 50 years (2019)
Attributed to:
King's Health Partners Confidence in Concept
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s13058-019-1143-y
PubMed Identifier: 31060593
Publication URI: http://europepmc.org/abstract/MED/31060593
Type: Journal Article/Review
Parent Publication: Breast Cancer Research
Issue: 1
ISSN: 1465-5411